07:00 , Aug 27, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact nformation Neurology Pain Cannabinoid CB1 receptor...
08:00 , Mar 10, 2003 |  BC Week In Review  |  Clinical News

Newron Pharmaceuticals SpA preclinical data

Researchers published in Pain that in mouse models of neuropathic pain, NW-1029 caused reductions in hyperalgesia. In two rat models of chronic pain, NW-1029 given either intraperitoneally or orally reduced allodynic responses and reversed mechanical...